abs133.txt	cervical	cancer	is	currently	the	fourth	leading	cause	of	death	among	womenworldwide		with	most	cases	occurring	in	low-	and	middle-income	countries	safe	highly	effective	vaccines	against	hpv	have	been	on	market	since	2006	yetonly	6%	girls	worldwide	received	this	life-saving	preventionintervention	international	organizations	including	path	gavi	thepharmaceutical	companies	merck	glaxosmithkline	provided	support	toeligible	to	implement	national	vaccinationprograms	still	glaring	disparities	availability	hpvvaccination	programs	coverage	primary	target	population	betweenthe	global	north	south	persist	we	illustrate	vaccineimplementation	using	an	online	data	visualization	which	publiclyavailable	can	be	used	gain	unique	insights	also	present	three	emergingsolutions	transform	future	vaccine	delivery	middle-incomecountries	low-cost	generics	single-dose	vaccination	co-administration	withother	adolescent	by	rapidly	expanding	access	togirls	everywhere	vaccine-type	infections	virtually	eliminated	athigh	vaccination-coverage	levels	more	than	80%-or	approximately	230	000-of	thecervical	deaths	that	occur	each	year	averted
